Personalized Medicine

Our technology will allow cancer immunotherapy to be effective on tumors that are not responsive to the current immunotherapeutic regimen. This will open new avenues and help growing the pool of potential cancer patients that can benefit from immunotherapy. Alexandre Motta, IMcoMET B.V.

Please rate this quote